For big pharma companies having a dynamic
pipeline of innovative products, Established Brands represent an essential
source of cash, while for less innovative ones, they are vital.
The « Value of Established Pharma Brands” provides strategic and tactical recommendations based on:
- Smart Pharma Consulting experience
- Literature search
- Interviews of 16 senior executives from six pharma companies.